Utilize este identificador para referenciar este registo:
|Título:||Comparative Bioavailability of two immediate release tablets of enalapril/hydrochlorothiazide in healthy volunteers|
|Palavras-chave:||Pharmacology & Pharmacy|
|Editora:||MEDECINE ET HYGIENE|
|Citação:||EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. - Vol. 27, n. 2 (APR-JUN 2002), p. 91-99|
|Resumo:||A bioequivalence study of two oral formulations of 20/12.5 mg tablets of enalaptil/hydrochlorothiazide was carried out in 20 healthy male volunteers according to a single dose, two-sequence, crossover randomized design. One washout period of nine days was observed between the two periods. Multiple samples were collected over 96 hours post-dosing. Bioavailability was evaluated on the basis of plasma concentrations of enalapril and its main active metabolite, enalaprilat and hydrochlorothiazide. Plasma samples were assayed for enalapril, enalaprilat and hydrochlorothiazide using a selective and sensitive high-performance liquid chromatography method with mass spectrometry detection (LC-MS). The pharmacokinetic parameter values of C-max and t(max) were obtained directly from plasma data, k(e) was estimated by log-linear regression, and AUC was calculated by trapezoidal rule. Different statistical tests were performed on the basis of untransformed and log-transformed data and the overall residual variance from ANOVA. Assuming the accepted tolerance intervals, a beta-error of 20% and 90% confidence intervals (alpha = 0.10), all the generally accepted tests (Schuirmann test and Wilcoxon-Tukey and Hauschke nonparametric tests) showed that the formulations can be considered as bioequivalent with respect to the extent of absorption, given by the AUC(0-infinity) and with respect to rate of absorption as assessed by C-max and t(max).|
|Aparece nas colecções:||FF - Produção Científica 2000-2009|
Ficheiros deste registo:
Não existem ficheiros associados a este registo.
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.